July 19, 2011 | Filed under: Health,News | Posted by:
In a 9-6 vote, an advisory panel said the FDA should not yet approve dapagliflozin, a new type of diabetes drug that makes the body dump sugar and lose weight. Signals of possible cancer and liver damage worried the experts.
Posted by
on July 19, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on July 19, 2011. Filed under